These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8319564)

  • 1. Evidence that luteinizing hormone suppression in response to inhibitory neuropeptides, beta-endorphin, interleukin-1 beta, and neuropeptide-K, may involve excitatory amino acids.
    Bonavera JJ; Kalra SP; Kalra PS
    Endocrinology; 1993 Jul; 133(1):178-82. PubMed ID: 8319564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hypothalamic peptides, beta-endorphin, neuropeptide K and interleukin-1 beta, and the opiate morphine, enhance the excitatory amino acid-induced LH release under the influence of gonadal steroids.
    Bonavera JJ; Sahu A; Kalra SP; Kalra PS
    J Neuroendocrinol; 1994 Oct; 6(5):557-64. PubMed ID: 7827626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diverse effects of tachykinins on luteinizing hormone release in male rats: mechanism of action.
    Kalra PS; Sahu A; Bonavera JJ; Kalra SP
    Endocrinology; 1992 Sep; 131(3):1195-201. PubMed ID: 1380435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tachykinins on luteinizing hormone release in female rats: potent inhibitory action of neuropeptide K.
    Sahu A; Kalra SP
    Endocrinology; 1992 Mar; 130(3):1571-7. PubMed ID: 1371455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous opioid peptides mediate the interleukin-1-induced inhibition of the release of luteinizing hormone (LH)-releasing hormone and LH.
    Kalra PS; Fuentes M; Sahu A; Kalra SP
    Endocrinology; 1990 Nov; 127(5):2381-6. PubMed ID: 2226323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that nitric oxide may mediate the ovarian steroid-induced luteinizing hormone surge: involvement of excitatory amino acids.
    Bonavera JJ; Sahu A; Kalra PS; Kalra SP
    Endocrinology; 1993 Dec; 133(6):2481-7. PubMed ID: 8243268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of neuropeptide-Y in episodic luteinizing hormone release in ovariectomized rats: an excitatory component and opioid involvement.
    Xu B; Sahu A; Crowley WR; Leranth C; Horvath T; Kalra SP
    Endocrinology; 1993 Aug; 133(2):747-54. PubMed ID: 8344213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that gonadal steroids modulate nitric oxide efflux in the medial preoptic area: effects of N-methyl-D-aspartate and correlation with luteinizing hormone secretion.
    Pu S; Xu B; Kalra SP; Kalra PS
    Endocrinology; 1996 May; 137(5):1949-55. PubMed ID: 8612535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aging results in attenuated gonadotropin releasing hormone-luteinizing hormone axis responsiveness to glutamate receptor agonist N-methyl-D-aspartate.
    Bonavera JJ; Swerdloff RS; Sinha Hakim AP; Lue YH; Wang C
    J Neuroendocrinol; 1998 Feb; 10(2):93-9. PubMed ID: 9535055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-1 inhibits the ovarian steroid-induced luteinizing hormone surge and release of hypothalamic luteinizing hormone-releasing hormone in rats.
    Kalra PS; Sahu A; Kalra SP
    Endocrinology; 1990 Apr; 126(4):2145-52. PubMed ID: 2180683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of N-methyl-D-aspartate receptor activation on cFos expression in luteinizing hormone-releasing hormone neurons in female rats.
    Lee WS; Abbud R; Hoffman GE; Smith MS
    Endocrinology; 1993 Nov; 133(5):2248-54. PubMed ID: 8404677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperprolactinemia suppresses the luteinizing hormone responses to N-methyl-D-aspartate, epinephrine, and neuropeptide-Y in male rats.
    Park SK; Selmanoff M
    Endocrinology; 1993 Nov; 133(5):2091-7. PubMed ID: 8404658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that stimulation of two modalities of pituitary luteinizing hormone release in ovarian steroid-primed ovariectomized rats may involve neuropeptide Y Y1 and Y4 receptors.
    Jain MR; Pu S; Kalra PS; Kalra SP
    Endocrinology; 1999 Nov; 140(11):5171-7. PubMed ID: 10537146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential inhibition of NMDA- and naloxone-induced LH release by NMDA receptor antagonist and CRH in ovariectomized estrogen-primed rats.
    Chiba A; Akema T; Nagami Y; Kimura F; Toyoda J
    Neuroendocrinology; 1997 Feb; 65(2):141-6. PubMed ID: 9067992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of galanin in stimulation of pituitary luteinizing hormone secretion as revealed by a specific receptor antagonist, galantide.
    Sahu A; Xu B; Kalra SP
    Endocrinology; 1994 Feb; 134(2):529-36. PubMed ID: 7507825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the luteinizing hormone and prolactin responses to multiple injections of kainate, as compared to N-methyl-D,L-aspartate, in cycling rats.
    Abbud R; Smith MS
    Endocrinology; 1991 Dec; 129(6):3254-8. PubMed ID: 1659525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of neuropeptide Y, NPY analog (norleucine4-NPY), galanin and neuropeptide K on LH release in ovariectomized (ovx) and ovx estrogen, progesterone-treated rats.
    Sahu A; Crowley WR; Tatemoto K; Balasubramaniam A; Kalra SP
    Peptides; 1987; 8(5):921-6. PubMed ID: 2448757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid-glutamate-nitric oxide connection in the regulation of luteinizing hormone secretion in the rat.
    Bhat GK; Mahesh VB; Ping L; Chorich L; Wiedmeier VT; Brann DW
    Endocrinology; 1998 Mar; 139(3):955-60. PubMed ID: 9492025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-methyl-D-aspartate treatment increases circulating adrenocorticotropin and luteinizing hormone in the rat.
    Farah JM; Rao TS; Mick SJ; Coyne KE; Iyengar S
    Endocrinology; 1991 Apr; 128(4):1875-80. PubMed ID: 1848504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 1 alpha inhibits prostaglandin E2 release to suppress pulsatile release of luteinizing hormone but not follicle-stimulating hormone.
    Rettori V; Gimeno MF; Karara A; Gonzalez MC; McCann SM
    Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2763-7. PubMed ID: 1901415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.